The 14th Scientific Congress of the Chinese Association for Laboratory Animal Science was held on October [11] [12] 2018 in Qingdao, China. During this congress, an international forum on the development of Laboratory Animal Sciences (LAS) worldwide was held in which participants learnt about the development of new LAS resources and technologies, as well as the progress of LAS in China.
The main points that were discussed are as follows.
After nearly a century of development, there are more than 200 species of experimental animals, and more than 20 000 inbred lines, outbred lines, genetic engineered animals, animal models of diseases, and other resources all over the world, which provide abundant experimental animal resources for scientific research. These resources are widely used in life science research. In the international forum, the topics that were discussed included the development of LAS; education and training; use and care of laboratory animals; relevant legislation; mouse resources, including development of inbred strains; the correct selection of animal disease models during drug development; and the application of using animal models in infectious diseases.
During the round-table discussion, experts affirmed the rapid development of LAS in China. As with the developed countries, LAS in China has experienced many challenges and problems and it is important to obtain advice and suggestions from international experts. According to their experience, education and training has been of great importance. Furthermore, with the development of LAS, correct use and care is becoming more and more crucial and, in this regard, it is very important to get mutual recognition, while at the same time, respecting different cultures.
The participants also showed great interest in the development of comparative medicine in China, as well as the development of modified animal models. Comparative medicine has been ascribed different meanings by various universities and research institutions.
Basically, it is a distinct discipline of experimental medicine that uses animal models of human and animal disease in translational and biomedical research. The development of comparative medicine in China led by Prof. Qin Chuan and her team (at ILAS) has its own characteristics and considers the similarities and differences between animal models and human diseases. Animal models of diseases that 1 In 2009, they developed the H1N1 transmission model to predict the risk of spread and the carrying of pathogens in animals in close contact with humans. 2 In 2010, the H5N1 model was developed to verify the transmission of virus via placenta. 3 In 2011, the first transgenic mouse model for Human
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Enterovirus 71 infection was developed to verify the function of virus receptors in vivo. 4 In 2013, ferret, mice, and pig models for H7N9 were developed to study the virus infection and transmission. 5, 6 Meanwhile, the nonhuman primate models for MERS infection were, respectively, developed on marmosets and rhesus macaques. 7, 8 They also established the nonhuman primate model for HIV study in China used since the 1980s, and the drug resistance and latent infection model for tuberculosis, These models have resolved the bottleneck in the study of infectious diseases study and drug development in China and other countries. [9] [10] [11] [12] In order to improve the reliability and repeatability of animal experimental results, the standardization of animal model development and evaluation technology in infectious diseases has been performed, which has solved the problem of poor reproducibility of animal experiment results. 13, 14 Based on the animal model system for the whole process of Finally, the development of the Gene Mine offers the potential for many new animal models of disease to be developed. Harnessing the genetic repertoire of the mouse species, the Gene Mine consists of dozens of recombinant inbred strains, resembling a large pedigree of dozens of "cousins" descended from eight "great-grandparents".
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Already, the Gene Mine has generated several unique models, including for diabetic retinopathy, 18 ulcerative colitis, right ventricular cardiomyopathy, achalasia, prostate hyperplasia, etc. The Gene
Mine is now based in ILAS, Beijing, where its phenotyping, genotyping and evaluation for diseases is ongoing.
CONFLI CT OF INTEREST
None.
O R C I D

Grant Morahan
https://orcid.org/0000-0002-8562-7325
